AVEFF (Avecho Biotechnology) Total Operating Expense: $4.53 Mil (TTM As of Dec. 2025)


What is Avecho Biotechnology Total Operating Expense?

Avecho Biotechnology AVEFF -74.14% Total Operating Expense is $4.53 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Avecho Biotechnology's Total Operating Expense for the six months ended in Dec. 2025 was $2.25 Mil. Avecho Biotechnology's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $4.53 Mil.

Avecho Biotechnology Total Operating Expense Related Terms

Avecho Biotechnology Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology Total Operating Expense Chart

Avecho Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.62 2.60 3.16 3.57 4.58

Avecho Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.26 2.06 1.60 2.29 2.25

Avecho Biotechnology Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $4.53 Mil mean?
Avecho Biotechnology (AVEFF) has a Total Operating Expense of $4.53 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Avecho Biotechnology and its competitors.
Is Avecho Biotechnology's Total Operating Expense too high?
Avecho Biotechnology's current Total Operating Expense is $4.53 Mil.
How does Avecho Biotechnology's Total Operating Expense compare to VRTX and REGN?
Avecho Biotechnology's Total Operating Expense of $4.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Avecho Biotechnology and its competitors. Avecho Biotechnology's current Total Operating Expense is $4.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (AVEFF) has a current Total Operating Expense of $4.53 Mil. The current Total Operating Expense is $4.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Avecho Biotechnology (AVEFF), the current Total Operating Expense is $4.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:GermanyAVE:Australia
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.